Assessment of vascular disease using arterial flow mediated dilatation.
Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 0
Abstract
Arterial endothelial dysfunction occurs at all stages of atherosclerosis, both preceding structural atherosclerosis changes, as well as predisposing to clinical events in late obstructive disease. Endothelial dysfunction is thus well correlated with risks of vascular events. Release of endothelial nitric oxide has been shown to be a key player in normal endothelial function. Endothelial function can be measured in the coronary arteries and peripheral vascular tree by intra-arterial infusion of substances that promote release of nitric oxide, but this method is limited by its invasive nature which limits its widespread use in asymptomatic subjects. Flow mediated dilatation is a non invasive ultrasound-based method where arterial diameter is measured in response to an increase in shear stress, which causes release of nitric oxide from the endothelium and consequent endothelium dependent dilatation. Flow mediated dilatation has been shown to correlate with invasive measures of endothelial function, as well as with the presence and severity of the major traditional vascular risk factors. This noninvasive endothelial function testing has also demonstrated the potential reversibility of endothelial dysfunction by various strategies including cessation of smoking, weight loss in obese subjects, certain pharmacological agents (statins, ACE inhibitors), L-arginine and hormones.
Authors and Affiliations
Sanjay Patel, David Celermajer
Keywords
Related Articles
- EP ID EP128853
- DOI -
- Views 115
- Downloads 0
Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.
New arylpiperazines with a four-methylene spacer containing a terminal pyrimido[2,1-f] theophylline fragment were synthesized, and their 5-HT1A and 5-HT2A receptor affinities were determined. All these compounds displaye...
Induction of P450 3A1/2 and 2C6 by gemfibrozil in Sprague-Dawley rats.
Fibrates are a group of peroxisome proliferator-activated receptor α agonists used in the treatment of dyslipidemia; however, they have been reported to cause species-related hepatocarcinogenesis and clinical myotoxicity...
Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances.
The aim of this study was to compare the action of fenofibrate on monocyte cytokine release between patients with isolated mixed dyslipidemia and dyslipidemia coexisting with prediabetic states in relationship with its m...
Effects of aspirin on the levels of hydrogen sulfide and sulfane sulfur in mouse tissues.
This study was designed to investigate the effect of aspirin (ASA) on anaerobic cysteine metabolism, which yields sulfane sulfur-containing compounds and hydrogen sulfide (H(2)S), in mouse liver and brain. In order to so...
Microarray analysis of altered gene expression in diallyl trisulfide-treated HepG2 cells.
Diallyl trisulfide (DT) is a natural compound derived from garlic. Despite its reported lipid-lowering effects, the mechanisms of its actions are not clear yet. To further understand the molecular mechanisms of actions o...